Bankrupt firm's subsidiary to buy CPEX
A subsidiary of a bankrupt New Jersey shoe company has agreed to buy CPEX Pharmaceuticals Inc., an Exeter, N.H., firm that develops alternative drug delivery systems. The price is $77.6 million, or $27.25 a share, the companies announced Tuesday morning.…
